Flow cytometric evaluation of bladder cancer: recommendations of the NCI flow cytometry network for bladder cancer
โ Scribed by R. L. Aamodt; J. S. Coon; A. Deitch; R. W. White; L. G. Koss; M. R. Melamed; R. S. Weinstein; L. L. Wheeless
- Book ID
- 104655390
- Publisher
- Springer-Verlag
- Year
- 1992
- Tongue
- English
- Weight
- 583 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0724-4983
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
At this present time, we feel that there is no role for DNA flow cytometry (FCM), or indeed DNA studies by any other method, to be used as a screening procedure for patients with no prior history of bladder cancer due to the high false-positive rate found when monitoring exfoliated urothelial cells.
Flow cytometric analysis was done on exfoliated urothelial cells from 11 control patients and 3 1 patients with transitional cell carcinoma: 9 grade I, 11 grade 11, and 11 grade 111. The determination of aneuploidy by DNA analysis did not provide identification of low-grade tumor cells. Other flow c
## Abstract Flow Cytometry (FCM) DNA assays of bladder irrigation specimens are now recognized as a clinically useful and reliable means of detecting and monitoring carcinoma of the bladder. This technique, which identifies carcinoma by the presence of an aneuploid population of cells, can be carri